Arkadios Wealth Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-26,555
Closed -$417K – 897
2024
Q1
$417K Buy
26,555
+16
+0.1% +$247 0.03% 432
2023
Q4
$429K Sell
26,539
-2,794
-10% -$45.7K 0.04% 406
2023
Q3
$361K Hold
29,333
– – 0.03% 425
2023
Q2
$471K Hold
29,333
– – 0.05% 323
2023
Q1
$511K Hold
29,333
– – 0.06% 300
2022
Q4
$271K Hold
29,333
– – 0.04% 434
2022
Q3
$253K Hold
29,333
– – 0.04% 425
2022
Q2
$239K Sell
29,333
-697
-2% -$6.65K 0.04% 466
2022
Q1
$365K Buy
30,030
+697
+2% +$14.7K 0.05% 385
2021
Q4
$1M Hold
29,333
– – 0.13% 180
2021
Q3
$1.42M Hold
29,333
– – 0.2% 121
2021
Q2
$1.32M Hold
29,333
– – 0.16% 160
2021
Q1
$1.41M Sell
29,333
-1,000
-3% -$52.1K 0.23% 113
2020
Q4
$1.63M Buy
+30,333
New +$1.37M 0.34% 81

Other funds holding NEO

Arkadios Wealth Advisors's NEO Position: Q2 2024 in Review

Arkadios Wealth Advisors sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 26,555 shares — an estimated $417K sold.

Arkadios Wealth Advisors first reported a position in NEO in Q4 2020 and held it in 14 quarters. The position peaked at $1.63M in Q4 2020. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Arkadios Wealth Advisors reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 26,555 NeoGenomics shares in Q2 2024, an estimated $417K.
  • Arkadios Wealth Advisors first reported a position in NeoGenomics in Q4 2020 and held it in 14 quarters.
  • Arkadios Wealth Advisors's NeoGenomics position peaked at $1.63M in Q4 2020.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.